Health architecture wins gongs
The importance of good design in health research and treatment facilities showed up in winning architecture.
The celebrity baby whisperer taking on Monash IVF
Australia's IVF industry is facing challenges balancing the needs of investors, patients and doctors.
Time for healthcare laggers?
Will underperformers like Sirtex Medical, Mayne Pharma and Healthscope will be able to restore investor confidence in their strategies?
Nobel Prize laureate passes the can around
Even Nobel Prize winners need to tap capital markets occasionally.
US congressman loses $22m on Aussie stock bet
The 92 per cent plunge in shares of biotech Innate Immunotherapeutics has cost a US congressman $22 million on paper.
What next for Blackmores?
Blackmores is likely to lean toward an internal appointment, with departing CEO Christine Holgate saying it's a great motivator and allows f...
Holgate leaves $4.2m on the table at Blackmores
So Christine Holgate finally scored her parachute out of vitamin darling Blackmores.
When heartache is not about love
Who knew that the drug that keeps stents open comes from soil on Easter Island?
Overturning traditional treatment for prostate cancer
Traditional management of prostate cancer is being overturned with the aim of helping men to live with the disease for decades.
Senate health bill to hit 22m
The Congressional Budget Office says the Senate's draft health-care bill will harm almost as many Americans as the House's.
